Bertelsmann Investments — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Ataraxis develops AI foundation models that analyze multi-modal patient data, including pathology slide images, to assess cancer aggressiveness and predict recurrence risk and treatment response.
AI & Machine LearningBiotechHealthtechNew York, US
Jan Witowski(Co-founder (physician-scientist))inKrzysztof Geras(Co-founder)inJan Witowski MD PhD(Founder)in
BoardKrish Ramadural(Director)Rohan Ganeshananthan(Director)
Co-investorsAIX VenturesFloating PointGiant Ventures Global LlpObvious VenturesTranspose Platform ManagementFounders Fund
YZR Capital is a founder-led, independent investment platform focused on healthcare innovation, backing early-stage to growth-stage companies across Europe.
Munich, DE
Co-investorsBeiersdorf Innovation FundPeakWave VenturesEuropean Investment FundKfW Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.